Concepedia

Dagmar E. Ehrnhoefer

DE

Statistics

Publications

31

Citations

4.5K

H-Index

24

Active since

2006

Affiliations

University of British Columbia(Current)

BioMed X Institute

Child and Family Research Institute

AbbVie (Germany)

European Molecular Biology Laboratory

Dagmar E. Ehrnhoefer is an author at University of British Columbia specializing in life sciences, neurodegenerative diseases, and neurodegenerative disorders.

ORCID

Publications per year

2006–2023

31

Publications

31

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

Dagmar E. Ehrnhoefer, Jan Bieschke, Annett Boeddrich et al. · Nature Structural & Molecular Biology · 2008 · 1.4K citations

, , +14

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

Jan Bieschke, Jenny Russ, Ralf P. Friedrich et al. · Proceedings of the National Academy of Sciences · 2010 · 1K citations · Full text

, , +17

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

Shu‐ichi Okamoto, Mahmoud A. Pouladi, Maria Talantova et al. · Nature Medicine · 2009 · 431 citations · Full text

, , +12

Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models

Dagmar E. Ehrnhoefer, Martin L. Duennwald, Phoebe Markovic et al. · Human Molecular Genetics · 2006 · 415 citations · Full text

, , +17

A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain

Ebru Ercan-Herbst, J Ehrig, David C. Schöndorf et al. · Acta Neuropathologica Communications · 2019 · 120 citations · Full text

, , +17

1–5 of 31